Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression

J. Hao, H. Chen, M. C. Madigan, P. J. Cozzi, J. Beretov, W. Xiao, W. J. Delprado, P. J. Russell, Y. Li*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

93 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression'. Together they form a unique fingerprint.

Medicine & Life Sciences